Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial

Abstract Background Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease, and its morbidity and mortality are increasing. At present, there is no specific therapy available. An exacerbated IFN-I response and cytokine storm are related to the mortality of pa...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Sai Wen, Nannan Xu, Lianhui Zhao, Lulu Yang, Hui Yang, Caiyun Chang, Shanshan Wang, Chunmei Qu, Li Song, Wenlu Zou, Yishan He, Gang Wang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-05-01
Sarja:	BMC Medicine
Aiheet:	Ruxolitinib Severe fever with thrombocytopenia syndrome Cytokine storm
Linkit:	https://doi.org/10.1186/s12916-024-03421-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!